Clinical Trial Update: Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pre-incisional ketorolac in surgery for non-small cell lung cancer or renal cell carcinoma has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

Sponsor: Emory University | Conditions: Non-small Cell Lung Cancer, Renal Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-03-04